Slide 1: Q1 2025 Financial Results
Q1 2025 Financial Results As of March 31, 2025, reported May 8, 2025 NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 1
Slide 2: Safe Harbor Statements
Safe Harbor Statements Certain statements contained in this presentation are "forward-looking statements." We have tried to identify these forward-looking statements by using words such as "may," "might," " will," "expect,” "anticipate,'' "'believe,“ "could," " intend," "plan," "estimate," "should,"
Slide 3: Sanjiv Razdan, CEO, President and Director
Sanjiv Razdan CEO, President and Director NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 3
Slide 4: Our mission is to improve quality of life through routine and affordable chiropractic care
Our mission is to improve quality of life through routine and affordable chiropractic care. Our vision is to build America’s most accessible health and wellness services company. NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 4
Slide 5: Multi-year, Phased Approach
Multi-year, Phased Approach 2.0 3.0 Strengthen Core Capture New Revenue & Become through Additional Pure Play Franchisor Channels & Markets NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 5
Slide 6: q bce
q bce
Slide 7: Initiate Dynamic Revenue Management
Initiate Dynamic Revenue Management Creating an innovative, flexible pricing model that aligns with treatment plans and patient usage NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 7
Slide 8: Strengthen Digital Marketing
Strengthen Digital Marketing • New content strategy aims to increase relevance and foster trust • New UGC focused on building authority and community validation NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 8
Slide 9: Strengthen Promotional Calendar
Strengthen Promotional Calendar • February 2025: Step into Wellness for active non- membership patients • June 2025: “Buy 5, Get 1” Wellness Sale semiannual event NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 9
Slide 10: Upgrade Patient-facing Technology
Upgrade Patient-facing Technology • Featured clinic finder, doctor in-clinic, in-clinic check-in, and push notifications • On track to be in clinics by June 30th NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 10
Slide 11: Jake Singleton, Chief Financial Officer
Jake Singleton Chief Financial Officer NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 11
Slide 12: Q1 2025 system-wide sales
5% 3% 7% Q1 2025 Q1 2025 Q1 2025 system-wide sales1 comp sales2 revenue from continuing operations 1 System-wide sales include revenues at all clinics, whether operated or managed by is important the company or by franchisees. While franchised sales are not recorded as revenues by the company, manag
Slide 13: Franchised Clinics 87% of Total Count
Franchised Clinics 87% of Total Count TOTAL CLINICS OPEN Franchised Company-owned and managed 967 969 935 125 122 838 135 126 706 96 579 513 64 442 60 399 48 842 847 370 47 800 312 61 712 47 610 246 515 4 453 394 352 309 242 265 175 82 12 26 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 202
Slide 14: Q1 2025 Continuing Operations as of Mar. 31, 2025
Q1 2025 Continuing Operations as of Mar. 31, 2025 $ in M 1 3 mo.s 3/31/25 3 mo.s 3/31/24 Differences Revenue $13.1 $12.2 $0.9 7% Cost of revenue 3.0 2.7 0.3 10% Sales and marketing 3.5 2.2 1.3 57% Depreciation and amortization 0.4 0.3 0.1 10% G&A 6.9 7.3 (0.4) (6)% Operating loss (0.7) (0.4) (0.3) N
Slide 15: Strong Liquidity
Strong Liquidity $ in Ms 3/31/25 12/31/24 Unrestricted cash $21.9 $25.1 Restricted cash $1.0 $0.9 Available JP Morgan Chase LOC1 $20.0 $20.0 Cash flow for the quarter end Mar. 31, 2025: • $(3.7)M used in operations • $(0.3)k for ongoing IT capex and small refreshes for corporate clinics • $ 0.9M fro
Slide 16: Reiterating 2025 Guidance
Reiterating 2025 Guidance 2024 2025 Low 2025 High $ in M Actual Guidance Guidance $530.3 $550 $570 System-wide sales 1 Comp sales for all clinics Mid-single digits open 13 months or more 2 4% Consolidated Adjusted EBTIDA 3 $11.4 $10.0 $11.5 New franchised clinic openings excluding the impact 57 30 4
Slide 17: Sanjiv Razdan, CEO, President and Director
Sanjiv Razdan CEO, President and Director NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 17
Slide 18: Life, Unpaused
Life, Unpaused 2025 Brand Campaign Consumer problem: Pain keeps people from living their best lives. NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 18
Slide 19: Life, Unpaused
Life, Unpaused 2025 Brand Campaign With routine chiropractic care, individuals reclaim their ability to move freely and fully embrace life’s experiences. NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 19
Slide 20: Strengthen Clinic Economics
Excel in Patient Build People Experience Capability & Culture Strengthen Clinic OUR Turbo Economics PATIENTS Charge Sales & Profits Innovate & & Reignite Broaden Relevance Growth Rapidly Grow Clinic Network 20 NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved.
Slide 21: Andra Terrell, SVP Legal
Andra Terrell Eric Wyatt SVP SVP Operations & NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. Legal Patient Experience 21
Slide 22: Sanjiv Razdan, President & CEO; Jake Singleton, CFO; Kirsten Chapman, LHA Investor Relations
Sanjiv Razdan, President & CEO sanjiv.razdan@thejoint.com anjiv.razdan@thejoint.com The Joint Corp. | 16767 N. Perimeter Dr., Suite 110, Scottsdale, AZ 85260 | (480) 245-5960 https://www.facebook.com/thejointchiro https://www.facebook.com/thejointchiro @thejointchiro Jake Singleton, CFO https://twit
Slide 23: Performance Metrics and Non-GAAP Measures
Performance Metrics and Non-GAAP Measures This presentation includes commonly discussed performance metrics. System-wide sales include revenues at all clinics, whether operated by the company or by franchisees. While franchised sales are not recorded as revenues by the company, management believes t
Slide 24: GAAP – Non-GAAP Reconciliation Q1 2025 vs. Q1 2024 by Category
GAAP – Non-GAAP Reconciliation Q1 2025 vs. Q1 2024 by Category Three Months Ended March 31, 2025 2024 from from from from Continuing Discontinued Net Continuing Discontinued Net Operations Operations Operations Operations Operations Operations Non-GAAP Financial Data: (Loss) Income $ (506,021) $ 1,3
Slide 25: GAAP – Non-GAAP Reconciliation Quarterly Continuing Operations
GAAP – Non-GAAP Reconciliation Quarterly Continuing Operations NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 25
Slide 26: GAAP – Non-GAAP Reconciliation Quarterly Discontinued Operations
GAAP – Non-GAAP Reconciliation Quarterly Discontinued Operations NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 26
Slide 27: GAAP – Non-GAAP Reconciliation Quarterly Consolidated Operations
GAAP – Non-GAAP Reconciliation Quarterly Consolidated Operations NASDAQ: JYNT | © 2025 The Joint Corp. All Rights Reserved. 27